Medtronic Inc (MDT) 74.08 $MDT
ModernGraham Quarterly Valuation Of Medtronic Inc.
Benjamin Clark - at Seeking Alpha - Thu Dec 25, 12:31AM CST
MDT: 74.08 (+0.31)
Final Glance: Medical Devices companies
AP - Wed Dec 24, 5:02PM CST
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 114.11 (+0.64), JNJ: 104.59 (+0.31), MDT: 74.08 (+0.31), BAX: 74.45 (-0.04)
United Therapeutics progresses on expanded label for Remodulin
Seeking Alpha - at Seeking Alpha - Wed Dec 24, 11:13AM CST
MDT: 74.08 (+0.31), UTHR: 130.22 (+2.40)
United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin
PR Newswire - Wed Dec 24, 10:26AM CST
United Therapeutics Corporation (NASDAQ: UTHR) announced today that Medtronic, Inc. (NYSE: MDT) has submitted a pre-market approval application to the U.S. Food and Drug Administration (FDA) for the use of Medtronic's SynchroMed® II implantable drug infusion system (including a newly developed catheter) for use with United Therapeutics' Remodulin® (treprostinil) Injection delivered intravenously to patients with pulmonary arterial hypertension.
MDT: 74.08 (+0.31), UTHR: 130.22 (+2.40)
Early Glance: Medical Devices companies
AP - Wed Dec 24, 9:23AM CST
NEW YORK (AP) — Shares of some top medical devices companies are up at 10 a.m.:
ZMH: 114.11 (+0.64), JNJ: 104.59 (+0.31), MDT: 74.08 (+0.31), BAX: 74.45 (-0.04)
Use of Composites in Orthopedic Industry to Reach $596 Million by 2020
PR Newswire Europe - Wed Dec 24, 3:57AM CST
NEW YORK and LONDON, December 24, 2014 /PRNewswire/ --
SNN: 38.18 (+0.14), JNJ: 104.59 (+0.31), MDT: 74.08 (+0.31), NUVA: 47.37 (+0.78), SYK: 96.00 (-0.61)
Midday Glance: Medical Devices companies
AP - Tue Dec 23, 12:22PM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 114.11 (+0.64), JNJ: 104.59 (+0.31), MDT: 74.08 (+0.31), BAX: 74.45 (-0.04)
The Market Finally Values K2M Group Holdings
Dallas Salazar - at Seeking Alpha - Tue Dec 23, 9:04AM CST
MDT: 74.08 (+0.31), KTWO: 20.53 (-0.08), SYK: 96.00 (-0.61)
IPO Stock Watch: Medical Device Maker Nevro Hits High
at Investor's Business Daily - Mon Dec 22, 4:45PM CST
JPMorgan raised its price target on Nevro (NVRO) to 42 from 34 and the stock rose 13% Monday, closing at an all-time high of 39.37. Nevro develops and markets an implantable spinal cord stimulation system called Senza, designed to treat chronic pain...
BSX: 13.13 (+0.07), JNJ: 104.59 (+0.31), MDT: 74.08 (+0.31), STJ: 66.67 (+0.67), NVRO: 37.95 (-0.93)
Watch for Medtronic to Potentially Pullback After Gaining 1.27% Yesterday
Comtex SmarTrend(R) - Mon Dec 22, 3:47PM CST
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $74.58 to a high of $75.64. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $75.00 on volume of 10.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 74.08 (+0.31)
SmarTrend Watching for Potential Pullback in Shares of Medtronic After 1.27% Gain
Comtex SmarTrend(R) - Mon Dec 22, 3:47PM CST
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $74.58 to a high of $75.64. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $75.00 on volume of 10.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 74.08 (+0.31)
Medtronic Drug-Coated Balloon for Peripheral Artery Disease Tops Standard Balloon Angioplasty in Landmark Study
Thomson Reuters ONE - Mon Dec 22, 2:00PM CST
MDT: 74.08 (+0.31)
Inspire Medical Systems to present at 33rd annual J.P. Morgan Healthcare Conference
PR Newswire - Mon Dec 22, 1:30PM CST
Inspire Medical Systems, Inc. announced today that Tim Herbert, president and CEO, will present an overview of the company's business at the 33rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for 8:00 a.m. PT on Monday, January 12, 2015, at the Westin St. Francis Hotel in San Francisco.
MDT: 74.08 (+0.31), JPM: 62.48 (unch)
Medtronic (MDT) Breaks Through Resistance at $75.08
Comtex SmarTrend(R) - Mon Dec 22, 11:39AM CST
Medtronic (NYSE:MDT) has opened bullishly above the pivot of $74.54 today and has reached the first level of resistance at $75.08. Analysts will be watching for a cross of the next upside pivot targets of $75.54 and $76.54.
MDT: 74.08 (+0.31)
United Therapeutics Lung Drug Keeps Going And Going
at Investor's Business Daily - Fri Dec 19, 4:20PM CST
Big-cap biotech and IBD 50 stock United Therapeutics has a history of confounding expectations -- in a good way. Almost exactly a year ago, the Food and Drug Administration approved Orenitram, a pill for treating pulmonary arterial hypertension...
MDT: 74.08 (+0.31), GILD: 91.29 (+1.84), PFE: 31.42 (-0.03), UTHR: 130.22 (+2.40), NVS: 93.91 (+0.66)
ModernGraham Quarterly Valuation Of Medtronic Inc.
Benjamin Clark - at Seeking Alpha - Thu Dec 25, 12:31AM CST
MDT: 74.08 (+0.31)
Final Glance: Medical Devices companies
AP - Wed Dec 24, 5:02PM CST
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 114.11 (+0.64), JNJ: 104.59 (+0.31), MDT: 74.08 (+0.31), BAX: 74.45 (-0.04)
United Therapeutics progresses on expanded label for Remodulin
Seeking Alpha - at Seeking Alpha - Wed Dec 24, 11:13AM CST
MDT: 74.08 (+0.31), UTHR: 130.22 (+2.40)
United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin
PR Newswire - Wed Dec 24, 10:26AM CST
United Therapeutics Corporation (NASDAQ: UTHR) announced today that Medtronic, Inc. (NYSE: MDT) has submitted a pre-market approval application to the U.S. Food and Drug Administration (FDA) for the use of Medtronic's SynchroMed® II implantable drug infusion system (including a newly developed catheter) for use with United Therapeutics' Remodulin® (treprostinil) Injection delivered intravenously to patients with pulmonary arterial hypertension.
MDT: 74.08 (+0.31), UTHR: 130.22 (+2.40)
Early Glance: Medical Devices companies
AP - Wed Dec 24, 9:23AM CST
NEW YORK (AP) — Shares of some top medical devices companies are up at 10 a.m.:
ZMH: 114.11 (+0.64), JNJ: 104.59 (+0.31), MDT: 74.08 (+0.31), BAX: 74.45 (-0.04)
Use of Composites in Orthopedic Industry to Reach $596 Million by 2020
PR Newswire Europe - Wed Dec 24, 3:57AM CST
NEW YORK and LONDON, December 24, 2014 /PRNewswire/ --
SNN: 38.18 (+0.14), JNJ: 104.59 (+0.31), MDT: 74.08 (+0.31), NUVA: 47.37 (+0.78), SYK: 96.00 (-0.61)
Midday Glance: Medical Devices companies
AP - Tue Dec 23, 12:22PM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 114.11 (+0.64), JNJ: 104.59 (+0.31), MDT: 74.08 (+0.31), BAX: 74.45 (-0.04)
The Market Finally Values K2M Group Holdings
Dallas Salazar - at Seeking Alpha - Tue Dec 23, 9:04AM CST
MDT: 74.08 (+0.31), KTWO: 20.53 (-0.08), SYK: 96.00 (-0.61)
IPO Stock Watch: Medical Device Maker Nevro Hits High
at Investor's Business Daily - Mon Dec 22, 4:45PM CST
JPMorgan raised its price target on Nevro (NVRO) to 42 from 34 and the stock rose 13% Monday, closing at an all-time high of 39.37. Nevro develops and markets an implantable spinal cord stimulation system called Senza, designed to treat chronic pain...
BSX: 13.13 (+0.07), JNJ: 104.59 (+0.31), MDT: 74.08 (+0.31), STJ: 66.67 (+0.67), NVRO: 37.95 (-0.93)
Watch for Medtronic to Potentially Pullback After Gaining 1.27% Yesterday
Comtex SmarTrend(R) - Mon Dec 22, 3:47PM CST
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $74.58 to a high of $75.64. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $75.00 on volume of 10.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 74.08 (+0.31)
SmarTrend Watching for Potential Pullback in Shares of Medtronic After 1.27% Gain
Comtex SmarTrend(R) - Mon Dec 22, 3:47PM CST
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $74.58 to a high of $75.64. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $75.00 on volume of 10.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 74.08 (+0.31)
Medtronic Drug-Coated Balloon for Peripheral Artery Disease Tops Standard Balloon Angioplasty in Landmark Study
Thomson Reuters ONE - Mon Dec 22, 2:00PM CST
MDT: 74.08 (+0.31)
Inspire Medical Systems to present at 33rd annual J.P. Morgan Healthcare Conference
PR Newswire - Mon Dec 22, 1:30PM CST
Inspire Medical Systems, Inc. announced today that Tim Herbert, president and CEO, will present an overview of the company's business at the 33rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for 8:00 a.m. PT on Monday, January 12, 2015, at the Westin St. Francis Hotel in San Francisco.
MDT: 74.08 (+0.31), JPM: 62.48 (unch)
Medtronic (MDT) Breaks Through Resistance at $75.08
Comtex SmarTrend(R) - Mon Dec 22, 11:39AM CST
Medtronic (NYSE:MDT) has opened bullishly above the pivot of $74.54 today and has reached the first level of resistance at $75.08. Analysts will be watching for a cross of the next upside pivot targets of $75.54 and $76.54.
MDT: 74.08 (+0.31)
United Therapeutics Lung Drug Keeps Going And Going
at Investor's Business Daily - Fri Dec 19, 4:20PM CST
Big-cap biotech and IBD 50 stock United Therapeutics has a history of confounding expectations -- in a good way. Almost exactly a year ago, the Food and Drug Administration approved Orenitram, a pill for treating pulmonary arterial hypertension...
MDT: 74.08 (+0.31), GILD: 91.29 (+1.84), PFE: 31.42 (-0.03), UTHR: 130.22 (+2.40), NVS: 93.91 (+0.66)
